Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × Neoplasms × Carboxypeptidases × Clear all

Status

Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1 Other hematologic neoplasm 1 Lymphoid 1

Conditions

Renal Insufficiency 1 Osteosarcoma 1 Neoplasms 1 Lymphoma 1 Leukemia 1

Interventions

vorasidenib 1 tovorafenib 1 olaparib 1 glucarpidase 1 enzalutamide 1 adagrasib 1 Nivolumab 1 Carboxypeptidases 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00481559 2014-01-17

Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity

BTG International Inc.

Approved for marketing

LymphoidOther hematologic neoplasmSarcoma

Leukemia, Lymphoma, Neoplasms, Osteosarcoma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡